Vanda Pharmaceuticals Inc. - Common Stock (VNDA)

CUSIP: 921659108

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / Common Stock
Shares outstanding
59,119,327
Total 13F shares
37,247,837
Share change
-4,076,585
Total reported value
$416,814,941
Put/Call ratio
36%
Price per share
$11.19
Number of holders
115
Value change
-$42,220,720
Number of buys
53
Number of sells
60

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 921659108?
CUSIP 921659108 identifies VNDA - Vanda Pharmaceuticals Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of VNDA - Vanda Pharmaceuticals Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
10%
5,996,691
$50,132,000 31 Mar 2016
13F
Palo Alto Investors LP
13F
Company
6.8%
4,030,908
$33,698,000 31 Mar 2016
13F
PAULSON & CO. INC.
13F
Company
6.6%
3,927,000
$32,830,000 31 Mar 2016
13F
GREAT POINT PARTNERS LLC
13F
Company
4.6%
2,731,210
$22,833,000 31 Mar 2016
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
3.7%
2,168,736
$18,131,000 31 Mar 2016
13F
Stonepine Capital Management, LLC
13F
Company
3.5%
2,068,297
$17,291,000 31 Mar 2016
13F
BlackRock Fund Advisors
13F
Company
2.8%
1,642,070
$13,728,000 31 Mar 2016
13F
ARMISTICE CAPITAL, LLC
13F
Company
2.7%
1,600,000
$13,376,000 31 Mar 2016
13F
VANGUARD GROUP INC
13F
Company
2.7%
1,596,278
$13,346,000 31 Mar 2016
13F
STATE STREET CORP
13F
Company
2.5%
1,488,367
$12,442,000 31 Mar 2016
13F
MORGAN STANLEY
13F
Company
2.4%
1,413,809
$11,819,000 31 Mar 2016
13F
MACQUARIE GROUP LTD
13F
Company
2.1%
1,229,942
$10,282,000 31 Mar 2016
13F
BlackRock Institutional Trust Company, N.A.
13F
Company
1.8%
1,093,279
$9,140,000 31 Mar 2016
13F
BANK OF MONTREAL /CAN/
13F
Company
1.8%
1,087,319
$9,090,000 31 Mar 2016
13F
J. Goldman & Co LP
13F
Company
1.5%
871,000
$7,282,000 31 Mar 2016
13F
Avoro Capital Advisors LLC
13F
Company
1.4%
854,579
$7,144,000 31 Mar 2016
13F
NORTHERN TRUST CORP
13F
Company
0.9%
529,253
$4,425,000 31 Mar 2016
13F
SPHERA FUNDS MANAGEMENT LTD.
13F
Company
0.87%
512,051
$4,281,000 31 Mar 2016
13F
KINGDON CAPITAL MANAGEMENT, L.L.C.
13F
Company
0.79%
464,568
$3,884,000 31 Mar 2016
13F
QS Investors, LLC
13F
Company
0.76%
447,733
$3,743,000 31 Mar 2016
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.71%
416,900
$3,485,000 31 Mar 2016
13F
DEUTSCHE BANK AG\
13F
Company
0.7%
412,819
$3,450,000 31 Mar 2016
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.64%
379,671
$3,173,000 31 Mar 2016
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.53%
312,906
$2,616,000 31 Mar 2016
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.51%
300,179
$2,510,000 31 Mar 2016
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.36%
211,246
$1,766,000 31 Mar 2016
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.35%
208,500
$1,743,000 31 Mar 2016
13F
Bank of New York Mellon Corp
13F
Company
0.34%
199,243
$1,665,000 31 Mar 2016
13F
BlackRock Investment Management, LLC
13F
Company
0.25%
149,999
$1,254,000 31 Mar 2016
13F
Convector Capital Management, LP
13F
Company
0.22%
132,000
$1,104,000 31 Mar 2016
13F
PDT Partners, LLC
13F
Company
0.22%
128,160
$1,071,000 31 Mar 2016
13F
Skandinaviska Enskilda Banken AB (publ)
13F
Company
0.2%
120,600
$1,008,000 31 Mar 2016
13F
COLUMBUS CIRCLE INVESTORS
13F
Company
0.18%
104,574
$874,000 31 Mar 2016
13F
CREDIT AGRICOLE S A
13F
Individual
0.17%
100,784
$843,000 31 Mar 2016
13F
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM
13F
Company
0.15%
88,844
$743,000 31 Mar 2016
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.15%
88,586
$741,000 31 Mar 2016
13F
CREDIT SUISSE AG/
13F
Company
0.14%
84,121
$703,000 31 Mar 2016
13F
FMR LLC
13F
Company
0.13%
78,200
$654,000 31 Mar 2016
13F
STRS OHIO
13F
Company
0.13%
76,627
$640,000 31 Mar 2016
13F
PERCEPTIVE ADVISORS LLC
13F
Company
0.12%
71,849
$601,000 31 Mar 2016
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.12%
69,999
$585,000 31 Mar 2016
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.12%
69,400
$580,000 31 Mar 2016
13F
PURA VIDA INVESTMENTS, LLC
13F
Company
0.11%
67,500
$564,000 31 Mar 2016
13F
VIRTUS ADVISERS, LLC
13F
Company
0.11%
67,021
$560,000 31 Mar 2016
13F
Swiss National Bank
13F
Company
0.11%
66,700
$538,000 31 Mar 2016
13F
CITADEL ADVISORS LLC
13F
Company
0.1%
60,743
$508,000 31 Mar 2016
13F
TEACHERS ADVISORS, LLC
13F
Company
0.1%
59,647
$499,000 31 Mar 2016
13F
CORNERSTONE CAPITAL MANAGEMENT HOLDINGS LLC.
13F
Company
0.1%
58,400
$488,000 31 Mar 2016
13F
Cheyne Capital Management (UK) LLP
13F
Company
0.09%
52,000
$434,000 31 Mar 2016
13F
Amici Capital, LLC
13F
Company
0.08%
50,000
$418,000 31 Mar 2016
13F

Institutional Holders of Vanda Pharmaceuticals Inc. - Common Stock (VNDA) as of Q2 2016

As of 30 Jun 2016, Vanda Pharmaceuticals Inc. - Common Stock (VNDA) was held by 115 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 37,247,837 shares. The largest 10 holders included DEERFIELD MANAGEMENT CO, Palo Alto Investors, LLC, PAULSON & CO. INC., GREAT POINT PARTNERS LLC, MORGAN STANLEY, VANGUARD GROUP INC, MACQUARIE GROUP LTD, BlackRock Fund Advisors, STATE STREET CORP, and BlackRock Institutional Trust Company, N.A.. This page lists 115 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2016 vs Q1 2016 Across Filers

Q1 2016 holders
115
Q2 2016 holders
115
Holder diff
0
Investor Q1 2016 Shares Q2 2016 Shares Share Diff Share Chg % Q1 2016 Value $ Q2 2016 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.